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Strengths and limitations of this study
 ► To the best knowledge of the investigators, this will 
be the first systematic review and meta-analyses in-
vestigating the proportion of women who had used 
their stored egg, the egg survival rate through vitri-
fication among women who underwent social egg 
freezing and the reproductive outcomes.
 ► Two reviewers will independently conduct abstracts 
and full-text screening, data extraction and risk-of-
bias assessment of the included studies.
 ► Social egg freezing is a recent application of assist-
ed reproductive technology; there may be a limited 
number of published studies.
 ► Since primary studies are likely to be limited to ob-
servational studies, confidence in estimates is likely 
to be low.
AbStrACt
Introduction Social egg freezing is storing egg for the 
purpose of preserving fertility and delayed childbearing. 
Currently, little is known about the utilisation and 
effectiveness of this approach. This review aims to 
determine (1) the proportion of women who used their 
stored eggs, and (2) the egg survival rate through 
vitrification, and the clinical pregnancy rate and live 
birth rate per 100 women partaking in the procedure, 
and among women who stored their eggs for medical 
reasons.
Methods and analyses This systematic review will 
be done according to the items listed in the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses statement. PubMed, Embase, Scopus, The 
Cumulative Index to Nursing and Allied Health Literature 
(CINAHL) and the Cochrane Library and Health Technology 
Assessment databases will be searched to identify 
eligible studies published since 2012. Two reviewers will 
independently appraise the eligibility and quality of the 
studies based on preset checklists and extract the data 
using a data extraction template. Outcomes of interest 
are proportion of women who used their stored eggs, 
egg survival rate, pregnancy rate and live birth rates. 
We will determine the presence heterogeneity among 
studies using the Cochrane’s Q test. The percentage of 
total variation across studies, which is due to statistical 
heterogeneity, will be calculated using the I2 statistics. 
Outcomes of interest will be pooled together using 
metaprop programme STATA V.14.
Ethics and dissemination For this review, ethical 
committee approval is not required. We will use publically 
available data from previously published studies. The 
final report of the review will be disseminated through 
publication on national or international journal, and it will 
be presented on different scientific conferences.
PrOSPErO registration number CRD42018114254.
IntrOduCtIOn
In women, fertility begins to decline in their 
fourth decade of life.1 Fecundity is well publi-
cised2; therefore, some women delay time of 
childbearing in order to fulfil other personal 
goals such as education, employment and/or 
overcome financial constraint.3 4 Relationship 
status has also been identified as a possible 
reason to preserve childbearing time.3 5 6 With 
the intention to share parenthood with a 
future partner, and defy the natural age-related 
fertility decline, some women have chosen 
to store their eggs,7–9 despite concerns about 
complications, limited success rates and costs.7 
A number of international companies such 
as Facebook, Google and Apple are offering 
female employees the chance to freeze their 
eggs, with the aim to give employees more 
freedom to pursue family planning according 
to their own timeline.10 11 This is variously 
labelled as ‘social egg freezing’, or ‘non-med-
ical egg freezing’ or ‘elective egg freezing.12 
The chance of having the desired outcomes 
such as high oocyte survival and live birth 
rates depend on womens’ age,13 the number 
of retrieved mature oocytes14 and the number 
of frozen eggs.13 Previous studies’ report lack 
agreement regarding the optimal timing 
of oocyte cryopreservation.9 14 15 One study 
showed the live birth rate was higher among 
women aged ≤35 years compared the older 
women (>35 years).14 Another study based on a 
decision analysis model verified that the prob-
ability of having live birth is the largest at the 










pen: first published as 10.1136/bmjopen-2019-030700 on 7 October 2019. Downloaded from 
2 Wang A, et al. BMJ Open 2019;9:e030700. doi:10.1136/bmjopen-2019-030700
Open access 
Figure 1 Preferred Reporting Items for Systematic Review 
and Meta-Analysis flow diagram for article selection and 
screening.
Despite the high media profile in recent times,16 17 
information about the effectiveness (live birth) and util-
isation of their stored egg18 and the long-term outcomes 
in family formation19 is scarce. Given the absence of 
systematic review and meta-analysis on the topic, this 
review will generate evidence on the proportions of 
women who used their stored eggs, egg survival rate 
and overall outcomes for women who store egg for 
fertility preservation that could help women to make 
informed decisions to freeze oocytes.2 18 Few individual 
study results demonstrate the diverse potential repro-
ductive outcomes of women who stored their egg for 
non-medical reasons. A study of 23 women who under-
went fertility preservation found that two women have 
used their stored eggs, of whom one of gave birth.20 In 
another study, of 875 women who had stored vitrified 
oocytes for future autologous in vitro fertilisation (IVF) 
treatment, 117 (13.4%) women returned to undergo 
IVF treatment.21 Two studies reported that 9.3%14 and 
6%6 of women have returned to use their stored eggs. In 
another study conducted in Melbourne Australia, of 91 
women who stored their egg for non-medical reasons, 6 
had used their stored oocytes, 3 of whom had given birth 
as a result. Of the three women who had not achieved a 
pregnancy with their stored oocytes, two had given birth 
after using fresh oocytes.18
The aim of this systematic review is to determine the 
proportion of women who used their stored egg (for 
non-medical reason) for autologous reproduction; to 
determine the effectiveness of social egg freezing (clin-
ical pregnancy rate and live birth rate); and to calculate 
egg survival rate through vitrification among women 
who underwent social egg freezing.
research questions
1. What proportion of women who had social egg freez-
ing used their eggs for autologous reproduction?
2. What is the egg survival rate through vitrification 
among women who underwent social egg freezing?
3. What is the effectiveness of social egg freezing, mea-
sured by clinical pregnancy rate and live birth rate per 
100 women undergoing social egg freezing?
4. What is the effectiveness of egg freezing, measured 
by clinical pregnancy rate and live birth rate per 100 
women who stored egg for medical reason?
MEthOdS
Protocol and registration
This protocol for systematic review is registered by the 
International Prospective Register of Systematic Reviews 
https://www. crd. york. ac. uk/ prospero/ searchad-
vanced. php.22 This protocol was written according 
to the recommendations of the Preferred Reporting 
Items for Systematic Review and Meta-Analysis Proto-
cols (PRISMA-P) 2015 statement. Components of the 
protocol were evaluated and addressed following items 
in the PRISMA-P checklist23 (online supplementary file 
1). We will include a proposed flow diagram that shows 
the search process (figure 1).
Search strategy
The primary literature search will be carried out from 
different databases. We will include studies from both 
English-language and non-English language articles 
published since 2012 when the American Society for 
Reproductive Medicine (ASRM) declared that egg 
freezing no longer be considered as experimental.24 
We will use a freely available web-based Babelfish and 
Bing translators to translate the non-English language 
articles into English. We will employ Medical Subject 
Headings (MeSH) terms, Emtree, CINAHL headings 
and combined keywords to identify studies in the data-
bases. We will use PubMed, Embase, Scopus, CINAHL, 
Health Technology Assessment, the Cochrane Library 
Databases, Translating Research into Practice, ProQuest 
Dissertations and Theses, and Conference Proceed-
ings Citation Index-Science to identify the relevant 
literatures for the review. The second author (FAK) 
will conduct all literature search, article retrieval and 
contact research authors for additional information 
if the paper is a conference preceding or in case of 
missing data. The search terms will emerge from the 
following keywords (social egg freezing, elective egg 
freezing, fertility preservation, delaying childbearing, 
non-medical egg freezing, oocyte freezing, oocyte cryo-
preservation, egg cryopreservation, oocyte survival, live 
birth) (online supplementary file 2). We will customise 
the search strategy for each database search. The review 
will be commenced on 1 May 2017 and completed on 
31 July 2019.
Eligibility criteria
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Study design
All observational studies (including prospective and 
retrospective cohort studies, case-control studies and 
cross-sectional studies) will be included.
Population
The study will include women who underwent social egg 
freezing. To be included, the literature should examine 
the proportion of women who had social egg freezing and 
used their eggs, egg survival rate through the freezing/
thawing process and/or live birth rate among women 
who underwent social egg freezing. A literature that 
examined egg survival rate, clinical pregnancy rate and 
live birth rate among women who stored egg for medical 
reasons will also be included into the review.
Intervention and comparisons
There is no intervention group. We will compare clin-
ical pregnancy rate and live birth rate among women of 
different age groups.
Outcomes
The primary outcomes of interest are proportion of 
women who used their stored egg, egg survival rate, preg-
nancy rate and live birth rate among women who under-
went social egg freezing. Secondary outcomes are egg 
survival rate, pregnancy rate and live birth rate among 
women who stored their egg for medical reason.
Exposures of interest
Age of the women at oocyte retrieval and vitrification is 
the main exposure for live birth rate. In addition, the 
total number of oocyte harvested, the number of oocytes 
thawed and survived, the number of oocytes fertilised, the 
number of embryos obtained and transferred, and the 
number of surplus embryos for cryopreservation are also 
exposure of interests.
Patient and public involvement
Patients were not involved in the development of this 
study protocol. This study will use publically available 
data without patient’s identification.
Study selection
The identified studies will be uploaded to Covidence25 
and duplicates will be removed. Two review authors (AW 
and FAK) will screen the abstract, and review full text 
papers independently based on information contained in 
titles and abstracts as per the inclusion criteria. We will 
obtain the full texts of all titles and abstracts that meet 
the inclusion criteria during the screening. Any discrep-
ancy between the two reviewers will be resolved through 
discussion. In the case of further disagreement, the fourth 
author (ZL) will arbitrate for the final decision. Studies 
that are not eligible will be excluded and the reasons for 
the exclusion will be described. A study will be excluded 
if it fulfils any of the following criteria: citations without 
abstracts; systematic reviews and meta-analysis; anony-
mous reports; duplicate studies. In addition, a study that 
does not report the number of women who used their 
stored egg and the outcome of the pregnancy (in terms 
of live birth) will be excluded. We will provide a supple-
mentary file for reference list of all excluded studies indi-
cating the reason(s) for exclusion.
data management
First, an initial set of studies will be identified by using 
the search terms and applying filters. We will use Covi-
dence to store all references selected for the review and 
all discarded references. We also use excel spreadsheet to 
manage the data. All information sources in the search 
such as databases with dates of coverage, contact with 
authors to acquire additional data and last date of litera-
ture search along with the full search strategy will be care-
fully recorded and reported.
risk of bias in included studies
We will use the Newcastle-Ottawa Scale (NOS)26 to assess 
the methodological quality of a study and to determine 
the extent to which a study has excluded or minimised 
the possibility of bias in its design, conduct and analysis. 
Attention will be given to clear description the objec-
tive of the study, identification of the study subjects and 
precise reports of exposure and outcomes of interest, as 
well as sources of bias or confounding.
data extraction process
For the data extraction, a structured data extraction form 
will be constructed. An Excel (Microsoft Corp, Redmond, 
WA) spreadsheet will be used for the data abstraction. 
Two reviewers (AW and FAK) will independently extract 
the data using a data extraction template. The template 
will include authors’ name, year of publication, the 
country where the study was undertaken, study design, 
sample size, the total number of oocyte harvested, the 
number of oocytes thawed and survived, the number of 
fertilised oocytes, the number of embryos obtained and 
transferred, and the number of surplus embryos for cryo-
preservation. In addition, the proportion of women who 
had social egg freezing and used their eggs, number of 
clinical pregnancies and live birth among women who 
undergoing social egg freezing and who stored their egg 
for medical reason will be abstracted. Any discrepancy 
during data abstraction will be resolved by discussion.
data synthesis and statistical analysis
Metabiases
The presence of small-study effects will be checked by 
using Doi plot and LFK index27 using MetaXL V.5.3,28 
which is an add-on for Microsoft Excel. We will imple-
ment influence analyses to check the effect of each study 
on combined effect size (ie, each study will be deleted 
from the model once in order to examine the effects of 
each study on the overall results for each outcome). We 
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Confidence in the cumulative evidence
The Grading of Recommendations Assessment, Devel-
opment and Evaluation29 tool will be used to evaluate 
the quality of evidence for all outcomes. We will eval-
uate the quality of evidence for the outcomes through 
the domains of risk of bias, indirectness, inconsistency, 
imprecision and small-study effects. The evaluation 
result will be presented in a summary table using four 
grades of certainty ratings: high, moderate, low and 
very low quality.
Calculation of effect sizes
A summary table will be prepared to describe the study 
characteristics of the included articles. Proportions of 
women who stored their egg for non-medical reason and 
used it, egg survival rate, pregnancy rate and live birth 
rate will be pooled together using metaprop programme30 
STATA (V.14, StataCorp, 2015). To calculate clinical preg-
nancy rate and live birth rate, women who got pregnant 
and with live birth will be used as a nominators; women 
who underwent social egg freezing and who underwent 
egg freezing for medical reason will be used as denomi-
nators. Mean age at the time of freezing oocytes, and at 
a time of fertilisation, and mean number oocyte stored 
will be computed. We will determine the presence hetero-
geneity among studies using Cochrane’s Q test. We will 
calculate the percentage of total variation across studies, 
which is attributed to heterogeneity, using the I2 statistics 
((Q−df)/Q where Q is Cochran’s heterogeneity statistic) 
(small, I2 <25%; moderate, 25%–49%; large, 50%–74%; 
very large >75%).31
The selection of the effect model (fixed-effect or 
random-effect model) will be based on the I2 statistics 
value (if the I2 <50%, the fixed-effect model will be used; 
if the I2 ≥50%, random-effect model will be used). Forest 
plots will be drawn to visualise effect size (proportions 
with 95% CI). For clinical pregnancy rate and live birth 
rate, subgroup analysis will also be conducted based on 
age of the women at oocyte verification, and at fertilisa-
tion (≤35 years and >35 years), and the average numbers 
oocyte stored. Where the studies are not suitable for 
quantitative analyses, we will present the data using narra-
tive synthesis.
Amendments to protocol
Not amended to date. If the protocol is amended, we 
will carefully report the change and a rationale for the 
change.
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